CytoSorbents Corporation is a critical care focused therapeutic device company using blood purification to treat life-threatening illnesses. The Company's purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Each polymer bead contains millions of pores and channels that can be modified to remove substances as small as drugs, to substances as large as antibodies.
South Brunswick Township, US
Size (employees)
65 (est)
Cytosorbents was founded in 2002 and is headquartered in South Brunswick Township, US
Report incorrect company information

Key People/Management at Cytosorbents

Phillip Chan

Phillip Chan

Chief Executive Officer and President
Kathleen Bloch

Kathleen Bloch

Chief Financial Officer
Vincent Capponi

Vincent Capponi

Chief Operating Officer
Robert Bartlett

Robert Bartlett

Chief Medical Officer

Cytosorbents Office Locations

Cytosorbents has an office in South Brunswick Township
South Brunswick Township, US (HQ)
k 7 Deerpark Dr
Show all (1)
Report incorrect company information

Cytosorbents Financials and Metrics

Cytosorbents Financials

Market capitalization (25-May-2018)

334.9 m

Closing share price (25-May-2018)

Cytosorbents's current market capitalization is $334.9 m.
Show all financial metrics
Report incorrect company information

Cytosorbents News and Updates

Report incorrect company information